GENEVA, July 18 -- CASCADE PHARMACEUTICALS, INC. filed a patent application (CN2025/133200) for “PHARMACEUTICAL COMPOSITION COMPRISING FXR AGONIST AND GLP-1 RECEPTOR SMALL MOLECULE AGONIST”. With publication no. WO/2026/148995, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: A61K 31/4545
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....